| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/01/2007 | US7211394 Providingformulation comprising a nascent protein comprising an affinity marker and a photocleavable detectable label, and ) a surface comprising an acceptor molecule; and interacting affinity marker with acceptor molecule so as to form a protein coated surface |
| 05/01/2007 | CA2189524C Aminomethyl-2,3,8,9-tetrahydro-7h-1,4-dioxino-[2,3e]indol-8-ones and derivatives |
| 05/01/2007 | CA2162630C Sulfonamides |
| 05/01/2007 | CA2132131C 3-arylbenzofuranones as stabilisers |
| 04/26/2007 | WO2007047991A1 Tetrahydroisoquinoline as lxr modulators |
| 04/26/2007 | WO2007047306A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | WO2007046550A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 04/26/2007 | WO2007045989A1 Pyridyl derivatives useful as h3 ligands |
| 04/26/2007 | WO2007045861A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 04/26/2007 | WO2007045420A2 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 04/26/2007 | WO2007045393A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | WO2006099075A3 Certain substituted amides, method of making, and method of use thereof |
| 04/26/2007 | WO2005105110A3 Doxepin analogs and methods of use thereof |
| 04/26/2007 | WO2004069139A3 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 04/26/2007 | US20070093660 Method for the production of statins |
| 04/26/2007 | US20070093535 Vinyl phenyl derivatives as GLK activators |
| 04/26/2007 | US20070093526 4-Amino-piperidine derivatives as monoamine uptake inhibitors |
| 04/26/2007 | US20070093512 4-Phenylaminopyrido[4,3-d]pyrimidines 6-heteroaryl-substituted, in which the heteroaryl is substituted with a sulfonylethylamino-, thio- or oxy- group; protein tyrosine kinase inhibitors, used especially to treat various malignancies |
| 04/26/2007 | US20070093506 Inhibitors of tyrosine kinases |
| 04/26/2007 | US20070093502 5- Or 6-substituted benzimidazole derivatives as inhibitors of respiratory syncytial virus replication |
| 04/26/2007 | US20070093483 Use of derivatives of 2, 4-dihydro-[1,2,4] triazole-3-thione as inhibitors of the enzyme myeloperoxidase (mpo) |
| 04/26/2007 | US20070093479 6-chloro-N-(3,3-dimethylbutyl)-5-phenyl-1H-indazol-3-amine; for treating neurodegenerative diseases such as Alzheimer's, fronto-parietal dementia, Pick's disease, Parkinson's disease, type II diabetes, corticobasal degeneration, in which phosphorylation of the tau protein is observed |
| 04/26/2007 | US20070093478 Novel mycobacterial inhibitors |
| 04/26/2007 | US20070093469 Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments |
| 04/26/2007 | US20070093456 Derivatives of gambogic acid and analogs as activators of caspases and inducers of apoptosis |
| 04/26/2007 | US20070092954 Production of polyketides |
| 04/26/2007 | DE102005049953A1 Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen Carbamoylbenzotriazol derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2829487A1 Organic compounds |
| 04/26/2007 | CA2625722A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases |
| 04/26/2007 | CA2625034A1 3-alkyl-5-(4-alkyl-5-oxo-tetrahydrofutran-2-yl)pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 04/26/2007 | CA2624904A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors |
| 04/26/2007 | CA2624166A1 Inhibitors of viral replication |
| 04/25/2007 | EP1777223A1 Indole derivatives useful as histamine H3 antagonists |
| 04/25/2007 | EP1777218A1 Process for the preparation of 4-phenoxy quinoline derivatives |
| 04/25/2007 | EP1776370A1 Cci-779 derivatives and methods of making same |
| 04/25/2007 | EP1776346A1 1,5-diphenylpyrazoles |
| 04/25/2007 | EP1776344A2 Quinoline derivatives as neurokinin receptor antagonists |
| 04/25/2007 | EP1776339A2 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
| 04/25/2007 | EP1537100B1 Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors |
| 04/25/2007 | EP1408950B1 Methods of treating cytokine mediated diseases |
| 04/25/2007 | EP1315710B1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 04/25/2007 | EP1305294B1 Imidazolyl derivatives |
| 04/25/2007 | EP0866656B1 Use of n-substituted pyridones as tumor necrosis factor alpha inhibitors |
| 04/25/2007 | CN1953976A Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain |
| 04/25/2007 | CN1953975A 2, 6 bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 04/25/2007 | CN1953974A Pyrimidine derivatives for the treatment of abnormal cell growth |
| 04/25/2007 | CN1953972A 1-amino-phthalazine derivatives, the preparation and the therapeutic use thereof |
| 04/25/2007 | CN1951918A Substituted pyridine herbicides |
| 04/25/2007 | CN1312148C Isochroman compounds for treatment of CNS disorders |
| 04/25/2007 | CN1312140C Lipid lowering biphenylcarboxamides |
| 04/25/2007 | CN1312137C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
| 04/25/2007 | CN1312127C 2-cyano-4-fluoropyrrolidine derivative or its salt |
| 04/24/2007 | US7208605 Functionalized ionic liquids, and methods of use thereof |
| 04/24/2007 | US7208602 N-sulfonyl- azetidines, pyrrolidines, piperidines and hexamethylenimines; treatment and prevention of Alzheimer's Disease and other diseases relating to the deposition of amyloid protein. |
| 04/24/2007 | US7208513 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 04/24/2007 | US7208512 Benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 04/24/2007 | US7208505 Treating Type 2 diabetes and/or obesity; compounds are indoles substituted at position 3 with a (3-(2-(heterocycle-substituted)phenoxy)-2-hydroxypropylamino)alkyl group |
| 04/24/2007 | US7208497 Substituted piperazines and diazepanes |
| 04/24/2007 | US7208495 Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof |
| 04/24/2007 | US7208493 Vasculostatic agents and methods of use thereof |
| 04/24/2007 | US7208488 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
| 04/24/2007 | US7208486 Vascular conditions such as atherosclerosis, hypercholesterolemia, diabetes, obesity, stroke, demyelination; lowering plasma levels of sterols and/or stanols |
| 04/24/2007 | US7208169 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
| 04/24/2007 | CA2281545C N-heterocyclic derivatives as nos inhibitors |
| 04/24/2007 | CA2197793C New multimerizing agents |
| 04/24/2007 | CA2194503C 2-[(dihydro)pyrazol-3'-yloxymethylene]anilides, their preparation and their use |
| 04/19/2007 | WO2007044515A1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/19/2007 | WO2007043653A1 Benzimidazole-5-carboxamide derivative |
| 04/19/2007 | WO2007043621A1 Total synthesis of pladienolide b and pladienolide d |
| 04/19/2007 | WO2007043484A1 Carbazole-containing amine compound and use thereof |
| 04/19/2007 | WO2007043457A1 Triarylcarboxylic acid derivative |
| 04/19/2007 | WO2007043401A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007043400A1 Nitrogenated aromatic heterocyclic compound and pharmaceutical composition comprising the same |
| 04/19/2007 | WO2007042912A2 Heterocyclic compounds as pstat3/il-6 inhibitors |
| 04/19/2007 | WO2007042906A1 Substituted benzofused derivatives and their use as vanilloid receptor ligands |
| 04/19/2007 | WO2007042810A1 Pyrimidine derivatives for the treatment of cancer |
| 04/19/2007 | WO2007042806A1 Pyrimidine derivatives for the treatment of cancer |
| 04/19/2007 | WO2007042669A2 Derivatives of 4-amino-quinazoline, preparation method thereof and use of same in therapeutics |
| 04/19/2007 | WO2007042668A1 Derivatives of 1-amino-isoquinoline, preparation method thereof and use of same in therapeutics in the treatment of a dysfunction associated with mch receptor 1 |
| 04/19/2007 | WO2007042660A2 Substituted 1-amino-phthalzine derivatives, preparation and therapeutic use thereof |
| 04/19/2007 | WO2007042546A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 04/19/2007 | WO2007042325A1 Antibacterial active 5-chinolin derivative |
| 04/19/2007 | WO2007020502A3 Cannabinoid receptor ligands and uses thereof |
| 04/19/2007 | WO2006131340A3 Pyrrolones that act as peptide deformylase (pdf) inhibitors |
| 04/19/2007 | WO2006047492A3 Substituted nitrogen-containing heterocycles as vanilloid receptor ligands and their uses as medicament |
| 04/19/2007 | WO2006034317A3 Chemical compounds |
| 04/19/2007 | US20070088080 Gsk-3 inhibitors isolated from marine organisms |
| 04/19/2007 | US20070088067 Novel amidine compounds for treating microbial infections |
| 04/19/2007 | US20070088060 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates |
| 04/19/2007 | US20070088054 Biphenyl derivatives |
| 04/19/2007 | US20070088044 Quinazoline derivatives as antitumor agents |
| 04/19/2007 | US20070088037 Cancer and fibrotic diseases |
| 04/19/2007 | US20070088033 Diaryl Substituted Pyridinones |
| 04/19/2007 | US20070088032 Processes for the Preparation of Benzoimidazole Derivatives |
| 04/19/2007 | US20070088018 Cb1 antagonist compounds |
| 04/19/2007 | US20070088016 5-substituted arylmethylidenyl (thio)xanthenes; hypotensive agents, antiinflammatory agents, antiarthritic agents; congestive heart failure |
| 04/19/2007 | US20070086944 Covalently binding an antioxidant such as ascorbic acid, p-aminobenzoic acid, cysteine, monothioglycerol, or gentisic acid with ligand: Oxa-PnAO, N,N-dimethyl Gly-Ser-Cys-Gly, N,N-dimethyl-Gly-t-butylGly-Cys-Gly, or 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; optional targeting molecule |
| 04/19/2007 | US20070085074 Merocyanine dye and use thereof |
| 04/19/2007 | CA2625974A1 Imidazole derivatives for the treatment of anxiety and related diseases |
| 04/19/2007 | CA2625687A1 Antibacterial active 5-chinolin derivative |